Coronary endothelial P-selectin in pathogenesis of myocardial ischemia-reperfusion injury.

We investigated in vivo coronary P-selectin expression and its pathophysiological consequences in a murine model of myocardial ischemia-reperfusion (MI/R) using wild-type and P-selectin deficient (-/-) mice. Coronary P-selectin expression [μg monoclonal antibody (MAb)/g tissue] was measured using a radiolabeled MAb method after 30 min of myocardial ischemia and 20 min of reperfusion. P-selectin expression in wild-type mice was significantly ( P< 0.01) elevated in the ischemic zone (0.070 ± 0.010) compared with the nonischemic zone (0.037 ± 0.008). Myocardial P-selectin expression was nearly undetectable in P-selectin -/- mice after MI/R. Furthermore, myocardial infarct size (% of area at risk) after 30 min of myocardial ischemia and 120 min of reperfusion was 42.5 ± 4.4 in wild-type mice and 24.4 ± 4.0 in P-selectin -/- mice ( P < 0.05). In additional experiments of prolonged myocardial ischemia (60 min) and reperfusion (120 min), myocardial infarct size was similar in P-selectin -/- mice and wild-type mice. Our results clearly demonstrate the involvement of coronary P-selectin in the development of myocardial infarction after MI/R.

[1]  V. Lindner,et al.  Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice. , 1997, Circulation.

[2]  D. Granger,et al.  Endothelial cell adhesion molecule expression in gene-targeted mice. , 1997, American journal of physiology. Heart and circulatory physiology.

[3]  E. Connolly,et al.  Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. , 1997, Circulation research.

[4]  A. Beaudet,et al.  Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[5]  R. Kloner,et al.  The effect of CY1503, a sialyl Lewisx analog blocker of the selectin adhesion molecules, on infarct size and "no-reflow" in the rabbit model of acute myocardial infarction/reperfusion. , 1997, Journal of molecular and cellular cardiology.

[6]  Eppihimer Mj,et al.  Ischemia/reperfusion-induced leukocyte-endothelial interactions in postcapillary venules. , 1997 .

[7]  T. Mayadas,et al.  Absence of P-selectin delays fatty streak formation in mice. , 1997, The Journal of clinical investigation.

[8]  A. Beaudet,et al.  The role of P-selectin and ICAM-1 in acute lung injury as determined using blocking antibodies and mutant mice. , 1996, Journal of immunology.

[9]  A. Buda,et al.  A sialyl Lewis(x)-containing carbohydrate reduces infarct size: role of selectins in myocardial reperfusion injury. , 1996, The American journal of physiology.

[10]  R. Mestril,et al.  Overexpression of heat shock protein 72 in transgenic mice decreases infarct size in vivo. , 1996, Circulation.

[11]  M. Labow,et al.  Heterogeneity of expression of E- and P-selectins in vivo. , 1996, Circulation research.

[12]  L. Horwitz,et al.  An oligosaccharide sialyl-Lewis(x) analogue does not reduce myocardial infarct size after ischemia and reperfusion in dogs. , 1996, Circulation.

[13]  D. Ramage,et al.  Leukocyte adhesion to the coronary microvasculature during ischemia and reperfusion in an in vivo canine model. , 1996, Circulation.

[14]  A. Buda,et al.  Effects of a monoclonal antibody directed against P-selectin after myocardial ischemia and reperfusion. , 1996, The American journal of physiology.

[15]  M. Entman,et al.  Myocardial ischemia and reperfusion: a murine model. , 1995, The American journal of physiology.

[16]  E. Topol,et al.  Adjunctive selectin blockade successfully reduces infarct size beyond thrombolysis in the electrolytic canine coronary artery model. , 1995, Circulation.

[17]  A. Beaudet,et al.  P-selectin/ICAM-1 double mutant mice: acute emigration of neutrophils into the peritoneum is completely absent but is normal into pulmonary alveoli. , 1995, The Journal of clinical investigation.

[18]  A. Buda,et al.  A novel sialyl LewisX analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion. , 1994, Circulation.

[19]  A. M. Lefer,et al.  Polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction. Role of selectins. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[20]  J. Perrard,et al.  Regulation of ICAM‐1 and IL‐6 in Myocardial Ischemia: Effect of Reperfusion a , 1994, Annals of the New York Academy of Sciences.

[21]  A. M. Lefer,et al.  Role of selectins, a new family of adhesion molecules, in ischaemia-reperfusion injury. , 1994, Cardiovascular research.

[22]  A. M. Lefer,et al.  Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats. , 1994, The Journal of clinical investigation.

[23]  M. Entman,et al.  Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium. , 1993, The Journal of clinical investigation.

[24]  M. Entman,et al.  P-selectin mediates spontaneous leukocyte rolling in vivo , 1993 .

[25]  T. Mayadas,et al.  Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice , 1993, Cell.

[26]  M. Topham,et al.  Inflammatory roles of P-selectin. , 1993, The Journal of clinical investigation.

[27]  M. Entman,et al.  Inflammation in Acute Coronary Syndromes , 1993, Circulation.

[28]  A. M. Lefer,et al.  In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. , 1993, The Journal of clinical investigation.

[29]  A. A. Taylor,et al.  Inflammation in the course of early myocardial ischemia , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  S. Werns,et al.  The role of the neutrophil and free radicals in ischemic myocardial injury. , 1989, Journal of molecular and cellular cardiology.

[31]  E. Braunwald,et al.  Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? , 1989, Circulation.

[32]  W. Barry.  Mechanisms of Myocardial Cell Injury during Ischemia and Reperfusion , 1987, Journal of cardiac surgery.

[33]  W. Nayler,et al.  Reperfusion injury: laboratory artifact or clinical dilemma? , 1986, Circulation.

[34]  E. Braunwald,et al.  Myocardial reperfusion: a double-edged sword? , 1985, The Journal of clinical investigation.

[35]  J. Lowe,et al.  The Wavefront Phenomenon of Ischemic Cell Death: 1. Myocardial Infarct Size vs Duration of Coronary Occlusion in Dogs , 1977, Circulation.